Business Context and Reporting Period
Company: National Health Investors, Inc. (NHI)
Filing Type: Form 8-K (Current Report)
Date of Report: April 20, 2026
Business Overview: NHI is a real estate investment trust (REIT) that owns and leases skilled nursing and independent living facilities. This filing discloses a material transaction involving the sale of a significant portion of its property portfolio to its primary tenant, National HealthCare Corporation (NHC).
Key Financial Metrics and Transaction Details
This filing does not report standard periodic financial metrics (revenue, profit, cash flow) but details a specific asset sale transaction:
- Transaction Value: $560 million purchase price (subject to adjustment).
- Assets Sold: 35 facilities total, comprising 32 skilled nursing facilities and 3 independent living facilities.
- Geographic Locations: Alabama, Florida, Kentucky, Missouri, South Carolina, Tennessee, and Virginia.
- Buyer: NHC/OP, L.P., a wholly-owned subsidiary of National HealthCare Corporation (NHC).
- Deposit Structure:
- Initial Deposit: $5 million (non-refundable after review period).
- Additional Deposit: $15 million (due if not terminated during review period).
- Seller's Liquidated Damages Deposit: $20 million (held by NHI, payable to buyer if NHI fails to close).
- Expected Closing: Third quarter of 2026.
Material Changes and Transaction Structure
The filing announces a definitive agreement to sell properties currently leased to the buyer under a Master Lease dated October 17, 1991. Key structural changes include:
- Lease Termination: Upon closing, the Master Lease will be terminated for the 35 sold facilities.
- Exception: Four skilled nursing facilities in Florida (subleased to a third party) will remain under the Master Lease, assigned to an NHC subsidiary.
- Related Party Status: NHC is a stockholder of NHI (owning 1,630,642 shares as of Dec 31, 2025). Robert G. Adams serves on both boards but is not standing for reelection at NHI.
- Approval: The transaction was unanimously approved by a Special Committee of Non-Interested Directors.
Outlook, Risks, and Contingencies
Outlook: The transaction is expected to close in Q3 2026, subject to customary conditions including the expiration of the Hart-Scott-Rodino Antitrust waiting period. There are no financing contingencies.
Risks and Contingencies:
- Closing Uncertainty: No assurance that closing conditions will be satisfied or that the transaction will be consummated.
- Termination Rights: The buyer has a "Review Period" ending May 29, 2026, during which they may terminate the agreement for any reason (with refund of the initial deposit).
- Market Impact: Risks include potential negative effects on NHI's stock price and operating results due to the announcement or consummation of the sale.
- Asset Condition: Properties are sold "as is," with the buyer bearing the risk of loss or damage prior to closing.
Investor Verification Checklist
- Verify the final closing date and whether the transaction proceeds as scheduled in Q3 2026.
- Confirm the final purchase price after any contractual adjustments.
- Review the impact of the sale on NHI's remaining portfolio composition and future rental income streams.
- Monitor the status of the Hart-Scott-Rodino Antitrust waiting period.
- Assess the financial impact of the $20 million liquidated damages deposit held by the company.